<DOC>
	<DOCNO>NCT02092506</DOCNO>
	<brief_summary>Triple therapy ( TT ) comprise proton pump inhibitor ( PPI ) , amoxicillin 1g clarithromycin 500mg twice daily long consider one standard treatment H. pylori infection initial study demonstrate success rate &gt; 90 % per protocol analysis ( PP ) &gt; 80 % intention treat ( ITT ) analysis . However increase bacterial resistance , especially clarithromycin , report concern efficacy TT decrease . Sequential therapy ( ST ) alternative first line therapy consist 5 day treatment PPI amoxicillin follow 5-day treatment PPI clarithromycin metronidazole . The rationale approach amoxicillin may weaken bacterial cell wall initial phase treatment , prevent development drug efflux channel inhibit clarithromycin binding ribosome thus help improve efficacy clarithromycin second phase treatment . A recent meta-analysis base mainly European study show success rate ST compare TT 92.8 - 96 % vs. 76.2 - 78.8 % . Concomitant therapy ( CT ) another alternative first line treatment consist 10 day PPI , amoxicillin , clarithromycin metronidazole . The rationale use CT first line treatment option address possibility clarithromycin resistance increasingly encounter clinical practice . Currently randomize control study compare TT ST Singapore , although regimen use routine clinical practice . The hypothesis ST superior TT first line treatment H. pylorus infection . The study aim compare 10-day TT versus 10-day ST versus 10-day CT first line treatment H. pylori infection Singapore .</brief_summary>
	<brief_title>RCT : Triple vs Sequential v Concomitant Therapy H Pylori</brief_title>
	<detailed_description>Background Helicobacter pylorus common infection Singapore overall seroprevalence rate 31 % . The prevalence rate increase age exceed 70 % among 65 year age ( 1 ) . H pylori major pathogen associate development peptic ulcer disease gastric malignancy successful H. pylorus eradication show important primary secondary prevention disease ( 2 ) . Triple therapy ( TT ) comprise proton pump inhibitor ( PPI ) , amoxicillin 1g clarithromycin 500mg twice daily long consider one standard treatment H. pylorus infection ( 2 , 3 ) initial study demonstrate success rate &gt; 90 % per protocol analysis ( PP ) &gt; 80 % intention treat ( ITT ) analysis . However increase bacterial resistance , especially clarithromycin , report concern efficacy TT decrease . Sequential therapy ( ST ) alternative first line therapy consist 5 day treatment PPI amoxicillin follow 5-day treatment PPI clarithromycin metronidazole . The rationale approach amoxicillin may weaken bacterial cell wall initial phase treatment , prevent development drug efflux channel inhibit clarithromycin binding ribosome thus help improve efficacy clarithromycin second phase treatment . A recent meta-analysis base mainly European study show success rate ST compare TT 92.8 - 96 % vs. 76.2 - 78.8 % ( 4 ) . Concomitant therapy ( CT ) another alternative first line treatment consist 10 day PPI , amoxicillin , clarithromycin metronidazole . The rationale use CT first line treatment option address possibility clarithromycin resistance increasingly encounter clinical practice ( 5 ) . Currently randomize control study compare TT ST Singapore , although regimen use routine clinical practice . The hypothesis ST superior TT first line treatment H. pylorus infection . Aim 10-day triple therapy ( TT ) [ twice daily proton pump inhibitor ( PPI ) , amoxicillin 1 g clarithromycin 500mg ] versus 10-day sequential therapy ( ST ) [ 5 day PPI amoxicillin 1g twice daily follow 5 day PPI , clarithromycin 500mg metronidazole 400mg twice daily ] versus 10-day concomitant therapy ( CT ) [ twice daily PPI , amoxicillin 1g , clarithromycin 500mg metronidazole 400mg ] first line treatment H. pylorus infection . Patients Methods Study Design : Prospective randomized control study . Treatment H. pylorus infect patient randomize treated use either 10 day TT ( PPI , amoxicillin 1g , clarithromycin 500mg twice daily ) 10-day ST ( PPI amoxicillin 1 g twice daily x 5 day follow PPI , clarithromycin 500mg , metronidazole 400mg twice daily x 5days ) 10-day CT ( PPI , amoxicillin 1g , clarithromycin 500mg , metronidazole 400mg twice daily ) . The success treatment define either negative carbon urea breath test ( CUBT ) negative histology perform 4 week completion treatment . CUBT histology perform base clinical indication determine attend physician . All patient PPI least 2 week , histamine 2 receptor antagonist least 1 week , prior assessment success treatment , per standard practice . The compliance treatment term percentage drug take assess clinic review . Antibiotic susceptibility test For patient H. pylori infection diagnose endoscopy positive rapid urease test kit , material test kit use send antibiotic susceptibility test whenever technically feasible . This may value guide choice antibiotic second line salvage treatment first line treatment fails . Statistical analysis : A treatment success rate 80 % regard minimum acceptable threshold empiric first line therapy . Data several country suggest success rate triple therapy may lower 80 % , whereas concomitant therapy may exceed 90 % . Thus study 80 % power significance level 5 % , minimum number patient recruit arm 138 high success rate 91 % low success rate 79 % . Randomization perform block 15 . Categorical data analyse use Chi-square Fisher exact test , continuous data analyse use student 's test . A p value &lt; 0.05 take statistically significant .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>consecutive patient newly diagnose H. pylori infection . know allergy treatment drug inability undergo routine test confirm success H. pylori eradication previous H. pylorus therapy .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>H pylorus</keyword>
	<keyword>therapy</keyword>
</DOC>